Bilateral risk for subsequent breast cancer after lobular carcinoma-in-situ: Analysis of surveillance, epidemiology, and end results data

Journal of Clinical Oncology

Volumn 23, Issue 24, 2005, Pages 5534-5541

  Chuba, Paul J ^a   Hamre, Merlin R ^a   Yap, Johnny ^a   Severson, Richard K ^a   Lucas, David ^a   Shamsa, Falah ^a   Aref, Amr ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER INCIDENCE; CANCER LOCALIZATION; CANCER REGISTRY; CANCER RISK; CARCINOMA IN SITU; CONTROLLED STUDY; HUMAN; LUNG CARCINOMA; MAJOR CLINICAL STUDY; MASTECTOMY; PRIORITY JOURNAL; BREAST TUMOR; CANCER INVASION; CHI SQUARE DISTRIBUTION; FEMALE; HYPERPLASIA; INCIDENCE; PATHOLOGY; POISSON DISTRIBUTION; RISK FACTOR; SURVIVAL; UNITED STATES;

BREAST NEOPLASMS; CARCINOMA IN SITU; CARCINOMA, LOBULAR; CHI-SQUARE DISTRIBUTION; FEMALE; HUMANS; HYPERPLASIA; INCIDENCE; NEOPLASM INVASIVENESS; POISSON DISTRIBUTION; RISK FACTORS; SEER PROGRAM; SURVIVAL ANALYSIS; UNITED STATES;

EID: 24944568952     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2005.04.038     Document Type: Article

References (42)

1. Foote FW Jr, Stewart FW: Lobular carcinoma in situ: A rare form of mammary cancer. Am J Pathol 17:491-496, 1941
2. Walt A, Simon M, Swanson GM: The continuing dilemma of lobular carcinoma in situ. Arch Surg 127:904-907, 1992
3. Goldschmidt RA, Victor TA: Lobular carcinoma in situ of the breast. Semin Surg Oncol 12:314-320, 1996
4. Anderson JA: Lobular carcinoma in situ of the breast: An approach to rational treatment. Cancer 39:2597-2602, 1977
5. Li CI, Anderson BO, Daling JR, et al: Changing incidence of lobular carcinoma in situ of the breast. Breast Cancer Res Treat 5:259-268, 2002
6. Yarbro JW, Page DL, Fielding LP, et al: American Joint Committee on Cancer Prognostic Factors Consensus Conference. Cancer 86: 2436-2446, 1999
7. Page DL, Schuyler PA, Dupont WD, et al: Atypical lobular hyperplasia as a unilateral predictor of breast cancer risk: A retrospective cohort study. Lancet 361:125-129, 2003
8. Haagensen CD, Lane N, Lattes R, et al: Lobular neoplasia (so-called lobular carcinoma in situ) of the breast. Cancer 42:737-769, 1978
9. Arpino G, Allred DC, Mohsin SK, et al: Lobular neoplasia on core-needle biopsy: Clinical significance. Cancer 101:242-250, 2004
10. Page DL, Kidd TE Jr, Dupont WD, et al: Lobular neoplasia of the breast: Higher risk for subsequent invasive cancer predicted by more extensive disease. Human Pathol 22:1232-1239, 1991
11. Fisher ER, Land SR, Fisher B, et al: Pathologic findings from the National Surgical Adjuvant Breast and Bowel Project: Twelve-year observations concerning lobular carcinoma in situ. Cancer 100:238-244, 2004
12. Levi F, Te VC, Randimbison L, et al: Trends of in situ carcinoma of the breast in Vaud, Switzerland. Eur J Cancer 33:903-906, 1997
13. Franceschi S, Levi F, La Vecchia C, et al: Second cancers following in situ carcinoma of the breast. Int J Cancer 77:392-395, 1998
14. Haagensen CD, Bodian C, Haagensen DE: Lobular Neoplasia (Lobular Carcinoma In Situ) Breast Carcinoma: Risk and Detection. Philadelphia, PA, WB Saunders, 1981, p 238
15. Fisher ER, Costantino J, Fisher B, et al: Pathologic findings from the National Surgical Adjuvant Breast Project (NSABP) Protocol B-17: Five year observations concerning tabular carcinoma in situ. Cancer 78:1403-1416, 1996
16. Ottesen GL, Graversen HP, Blichert-Toft M, et al: Carcinoma in situ of the female breast. 10 year follow-up results of a prospective nationwide study. Breast Cancer Res Treat 62:197-210, 2000
17. Fisher B, Constantino JP, Wickerman DL, et al: Tamoxifen for prevention of breast cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. J Natl Cancer Inst 90:1371-1388, 1998
18. National Cancer Institute: Surveillance, Epidemiology, and End Results (SEER) Program Public-Use CD-ROM (1973-1998). Bethesda, MD, National Cancer Institute, 1999
19. Percy C, Fritz A, Jack A, et al: (eds): International Classification of Diseases for Oncology (ed 3). Geneva, Switzerland, World Health Organization, 2000
20. Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Statist Assoc 53:457-481, 1958
21. Lee ET: Statistical Methods for Survival Analysis. Belmont, CA, Lifetime Learning Publications, 1980
22. Snedecor GW, Cochran WG: Statistical Methods (ed 7). Ames, IA, The Iowa State University Press, 1980
23. Salvadori B, Bartoli C, Zurrida S, et al: Risk of invasive cancer in women with lobular carcinoma in situ of the breast. Eur J Cancer Clin Oncol 27:35-37, 1991
24. Akashi-Tanaka S, Fukutomi T, Nanasawa T, et al: Treatment of non-invasive carcinoma: Fifteen year results at the National Cancer Center Hospital in Tokyo. Breast Cancer 7:341-344, 2000
25. Rosen PP, Braun DW, Lynggholm B, et al: Lobular carcinoma in situ of the breast: Preliminary results of treatment by ipsilateral mastectomy and contralateral breast biopsy. Cancer 47:813-819, 1981
26. Rosen PP, Lieberman PH, Braun DW Jr, et al: Lobular carcinoma in situ of the breast. Am J Surg Pathol 2:225-251, 1978
27. Devarahally SR, Severson RK, Chuba P, et al: Second malignant neoplasms after primary central nervous system malignancies of childhood and adolescence. Pediatr Hematol Oncol 20:617-625, 2003
28. Hamre MR, Severson RK, Chuba P, et al: Osteosarcoma as a second malignant neoplasm. Radiother Oncol 65:153-157, 2002
29. Yap J, Chuba PJ, Thomas R, et al: Sarcoma as a second malignancy after treatment for breast cancer. Int J Radiat Oncol Biol Phys 52:1231-1237, 2002
30. Ottesen GL, Graversen HP, Blichert-Toft M, et al: Lobular carcinoma in situ of the female breast: Short-term results of a prospective nationwide study. Am J Surg Pathol 17:14-21, 1993
31. Wheeler JE, Enterline HT, Roseman JM, et al: Lobular carcinoma in situ of the breast: Long-term follow-up. Cancer 34:554-563, 1974
32. Bodian CA, Perzin KH, Latter R: Lobular neoplasia: Long term risk of breast cancer in relation to other factors. Cancer 78:1024-1034, 1996
33. Marshall LM, Hunter DJ, Connolly JL, et al: Risk of breast cancer associated with atypical hyperplasia of lobular and ductal types. Cancer Epidemiol Biomarkers Prev 6:297-301, 1997
34. Colditz GA, Rosner B: Cumulative risk of Breast cancer to age 70 years according ot risk factor status: Data from the Nurses' Health Study. Am J Epidemiol 152:950-964, 2000
35. Sasson AR, Fowblè B, Hanlon AL, et al: Lobular carcinoma in situ increases the risk of local recurrence in selected patients with stages I and II breast carcinoma treated with conservative surgery and radiation. Cancer 91:1862-1869, 2001
36. Stone JG, Coleman G, Gusterson B, et al: Contribution of germline MLH1 and MSH2 mutations to lobular carcinoma in situ of the breast. Cancer Lett 167:171-174, 2001
37. Goldstein NS, Kestin LL, Vicini FA: Clinicopathologic implications of E-cadherin reactivity in patients with lobular carcinoma in situ of the breast. Cancer 92:738-747, 2001
38. Rieger-Chris KM, Pezza JA, Dugan JM, et al: Disparate E-cadherin mutations in LCIS and associated invasive breast carcinomas. Mol Pathol 54:91-97, 2001
39. Lu YJ, Osin P, Lakhani SR, Bt al: Comparative genomic hybridization analysis of lobular carcinoma in situ and atypical lobular hyperplasia and potential roles for gains and losses of genetic material breast neoptasia. Cancer Res 58: 4721-4727, 1998
40. Etzell JE, Devries S, Chew K, et al: Loss of chromosome 16q in lobular carcinoma in situ. Hum Pathol 32:292-296, 2001
41. Abner AL, Connolly JL, Recht A, et al: The relation between, the presence and extent of lobular carcinoma in situ and the risk of local recurrence for patients with invasive carcinoma of the breast treated with conservative, surgery and radiation therapy. Cancer 88:1072-1077, 2000
42. Zippin C, Lum BS, Hankey BF: Completeness of hospital cancer case reporting from the SEER program of the National Cancer Institute. Cancer 76:2343-2350, 1995